(Q70646458)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

12 October 2019

main subject

0 references

author name string

E Röther

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

B Lang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

R Coldewey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

K Hartung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

H H Peter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 March 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

31-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma

12 October 2019

cites work

1 reference

12 December 2020

The C1q binding assay in systemic lupus erythematosus

1 reference

12 December 2020

Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus

1 reference

12 December 2020

Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis

1 reference

12 December 2020

Effectiveness of testing for anti-DNA and the complement components iC3b, Bb, and C4 in the assessment of activity of systemic lupus erythematosus

1 reference

12 December 2020

Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes

1 reference

12 December 2020

Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus

1 reference

12 December 2020

Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study

1 reference

12 December 2020

The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus

1 reference

12 December 2020

Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis

1 reference

12 December 2020

Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity

1 reference

12 December 2020

Measurement of circulating immune complexes containing IgG, IgM, IgA and IgE by flow cytometry: correlation with disease activity in patients with systemic lupus erythematosus

1 reference

12 December 2020

The relationship of anti-DNA antibody idiotypes and anti-cardiolipin antibodies to disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

1 reference

12 December 2020

Anti-dsdna and complement profiles as prognostic guides in systemic lupus erythematosus

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis

1 reference

12 December 2020

Useful laboratory measurements in the management of systemic lupus erythematosus

1 reference

12 December 2020

The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

Prognostic value of anti-dsDNA in SLE

1 reference

12 December 2020

Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study

1 reference

12 December 2020

The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus

1 reference

12 December 2020

C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Metabolic Studies of the Third Component of Complement and the Glycine-Rich Beta Glycoprotein in Patients with Hypocomplementemia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02231555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8467609%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference